Formula Growth
ATRC icon

Formula Growth’s AtriCure ATRC Stock Holding History

Formula Growth’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.04M Buy
+18,500
New +$834K 0.4% 99

Other funds holding ATRC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return

Formula Growth's ATRC Position: Q3 2026 in Review

Formula Growth opened a new position in AtriCure (ATRC) in Q3 2026: 18,500 shares worth $1.04M. The stake represents 0.4% of the portfolio and ranks #99 among its holdings.

221 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Formula Growth held 18,500 shares of AtriCure worth $1.04M as of Q3 2026.
  • AtriCure was a new Formula Growth position in Q3 2026.
  • AtriCure made up 0.4% of Formula Growth's portfolio in Q3 2026, its #99 holding.
  • 221 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Formula Growth's 13F filing for Q3 2026, filed 13 Nov 2026.